Concord Biotech Limited
NSE: CONCORDBIO · Healthcare
₹1,548.00
+8.60 (+0.56%)
Last close · 30 Aug 2026, 10:38 am IST
- Open
- ₹1,557.00
- Day high
- ₹1,560.00
- Day low
- ₹1,523.20
- Volume
- 53.6 K
- Prev close
- ₹1,539.40
Price chart
Range
EMA
Also show
Fundamentals
Biotechnology
Valuation
- Market Cap
- 13,061 Cr
- Price
- 1,248.50
- P/E (TTM)
- 50.51
- P/E (Fwd)
- 30.42
- P/B
- 6.48
- EV/EBITDA
- 33.51
- EV/Revenue
- 11.97
- PEG
- —
- Div Yield
- 0.60%
- 52W High
- 1,905.00
- 52W Low
- 987.00
- Beta
- 0.42
Profitability & income
- Revenue (TTM)
- 1,055 Cr
- Net Income (TTM)
- 261 Cr
- EBITDA
- 377 Cr
- Gross Margin
- 64.14%
- Op. Margin
- 33.84%
- Net Margin
- 24.73%
- ROE
- 13.54%
- ROA
- 8.91%
- EPS (TTM)
- 24.72
- EPS (Fwd)
- 41.05
Financial health
- Total Debt
- 2 Cr
- Total Cash
- 432 Cr
- Debt/Equity
- 0.12
- Current Ratio
- 7.39
- Quick Ratio
- 5.34
- Book Value
- 192.81
- Free Cash Flow
- 137 Cr
- Op. Cash Flow
- 267 Cr
Growth
- Revenue Growth
- -24.10%
- Earnings Growth
- -37.00%
- Earnings QoQ
- -36.80%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 326 Cr | 89 Cr | 134 Cr | 99 Cr | 240 Cr | — | 2 Cr | 2,017 Cr |
| 2025-12-31 | 278 Cr | 64 Cr | 105 Cr | 80 Cr | 212 Cr | — | — | — |
| 2025-09-30 | 247 Cr | 63 Cr | 104 Cr | 70 Cr | 198 Cr | — | 2 Cr | 1,827 Cr |
| 2025-06-30 | 204 Cr | 44 Cr | 77 Cr | 44 Cr | 159 Cr | — | — | — |
| 2025-03-31 | 430 Cr | 140 Cr | 198 Cr | 176 Cr | 301 Cr | — | 3 Cr | 1,813 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,046 Cr | 261 Cr | 419 Cr | 305 Cr | 786 Cr | 267 Cr | 2 Cr | 2,017 Cr |
| 2025-03-31 | 1,180 Cr | 372 Cr | 549 Cr | 463 Cr | 862 Cr | 245 Cr | 3 Cr | 1,813 Cr |
| 2024-03-31 | 998 Cr | 308 Cr | 469 Cr | 386 Cr | 756 Cr | 265 Cr | 10 Cr | 1,527 Cr |
| 2023-03-31 | 831 Cr | 240 Cr | 381 Cr | 305 Cr | 634 Cr | 246 Cr | 32 Cr | 1,290 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for CONCORDBIO?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in